
From OHC
April 16, 2014
We’re exceptionally proud of our contributions to cancer research. Led by OHC Clinical Research Department Chief Dr. David Waterhouse and Director Lynnetta Hart — and a team of nearly 30 dedicated cancer researcher specialists — OHC is the Tri-state’s largest clinical trials provider for adults with cancer.
Being just one of seven strategic clinical trial sites for Sarah Cannon Research Institute, OHC is the recognized leader in cancer trials research.